Sudarshan Pharma (SUDARSHAN) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
5.1B
Gross Profit
652.9M
12.93%
Operating Income
377.0M
7.46%
Net Income
159.5M
3.16%
Balance Sheet Metrics
Total Assets
4.0B
Total Liabilities
2.7B
Shareholders Equity
1.3B
Debt to Equity
2.06
Cash Flow Metrics
Operating Cash Flow
8.5M
Free Cash Flow
304.8M
Revenue & Profitability Trend
Sudarshan Pharma Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.1B | 4.6B | 4.6B | 3.6B | 1.9B |
| Cost of Goods Sold | 4.4B | 4.2B | 4.3B | 3.4B | 1.8B |
| Gross Profit | 652.9M | 410.6M | 297.2M | 191.9M | 140.5M |
| Operating Expenses | 204.8M | 186.8M | 108.2M | 51.1M | 48.3M |
| Operating Income | 377.0M | 215.7M | 144.2M | 102.0M | 64.2M |
| Pre-tax Income | 216.3M | 152.3M | 95.0M | 71.9M | 35.7M |
| Income Tax | 56.8M | 37.7M | 24.6M | 18.9M | 9.0M |
| Net Income | 159.5M | 114.6M | 70.4M | 53.0M | 26.7M |
| EPS (Diluted) | - | ₹0.47 | ₹0.55 | ₹2.20 | ₹1.11 |
Income Statement Trend
Sudarshan Pharma Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 3.3B | 2.4B | 2.0B | 1.3B | 876.4M |
| Non-Current Assets | 675.6M | 415.5M | 338.6M | 79.4M | 116.2M |
| Total Assets | 4.0B | 2.8B | 2.3B | 1.4B | 992.6M |
| Liabilities | |||||
| Current Liabilities | 2.6B | 1.6B | 1.2B | 1.0B | 712.2M |
| Non-Current Liabilities | 112.3M | 105.9M | 130.3M | 67.1M | 55.3M |
| Total Liabilities | 2.7B | 1.7B | 1.3B | 1.1B | 767.5M |
| Equity | |||||
| Total Shareholders Equity | 1.3B | 1.1B | 1.0B | 297.8M | 225.1M |
Balance Sheet Composition
Sudarshan Pharma Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 216.3M | 152.3M | 95.0M | 71.9M | 35.7M |
| Operating Cash Flow | 8.5M | 472.8M | -457.4M | -323.8M | -247.4M |
| Investing Activities | |||||
| Capital Expenditures | -47.5M | -37.8M | -138.0M | -16.6M | -13.2M |
| Investing Cash Flow | -47.1M | -65.2M | -138.0M | -16.6M | -13.2M |
| Financing Activities | |||||
| Dividends Paid | - | -7.2M | - | - | - |
| Financing Cash Flow | 11.1M | -8.6M | - | 64.4M | 5.1M |
| Free Cash Flow | 304.8M | 39.7M | -426.0M | -53.9M | 14.7M |
Cash Flow Trend
Sudarshan Pharma Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
42.62
Price to Book
5.19
Price to Sales
1.34
Profitability Ratios
Profit Margin
3.16%
Operating Margin
8.02%
Return on Equity
13.12%
Return on Assets
6.87%
Financial Health
Current Ratio
1.29
Debt to Equity
129.85
Beta
1.52
Per Share Data
EPS (TTM)
₹0.66
Book Value per Share
₹5.42
Revenue per Share
₹20.90
Financial data is updated regularly. All figures are in the company's reporting currency.